Laura Okpala

Company: Gilead Sciences

Job title: Executive Director, Head of Reimbursement Policy

Bio:

At Gilead Sciences, Ms. Okpala leads the US reimbursement policy team focused on driving access to innovative medicines across Gilead’s oncology and virology portfolio, including reimbursement strategies for Kite Pharma, a leader in the development of novel CAR T therapies.

Seminars:

Are Reimbursement Systems Ready to Accommodate Outpatient- Administered CGTs? 9:00 am

Understanding the drivers behind the increasing number of CGTs being administered in the outpatient setting, and whether current infrastructure is equipped to manage this growth Sharing strategies to work with states to overcome barriers to access Setting out a roadmap of improvements needed in reimbursement systems to support outpatient administrationRead more

day: Conference Day One